MARKET

PCRX

PCRX

Pacira Biosciences Inc
NASDAQ
21.88
-0.48
-2.15%
Opening 14:13 01/21 EST
OPEN
22.23
PREV CLOSE
22.36
HIGH
22.88
LOW
21.88
VOLUME
246.00K
TURNOVER
--
52 WEEK HIGH
34.01
52 WEEK LOW
11.16
MARKET CAP
1.01B
P/E (TTM)
-10.0913
1D
5D
1M
3M
1Y
5Y
1D
Pacira Names Brendan Teehan Chief Commercial Officer, Krys Corbett Chief Business Officer
NASDAQ · 5h ago
Pacira Pharmaceuticals Announces Leadership Changes and Plan Amendment
TipRanks · 5h ago
Pacira appoints Teehan as CCO, Corbett as CBO
TipRanks · 5h ago
PACIRA BIOSCIENCES STRENGTHENS EXECUTIVE LEADERSHIP TEAM WITH TWO KEY APPOINTMENTS
Reuters · 6h ago
Press Release: Pacira BioSciences Strengthens Executive Leadership Team with Two Key Appointments
Dow Jones · 6h ago
Press Release: Pacira BioSciences Strengthens -2-
Dow Jones · 6h ago
Weekly Report: what happened at PCRX last week (0113-0117)?
Weekly Report · 1d ago
PCRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Pacira BioSciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Barchart · 4d ago
More
About PCRX
Pacira BioSciences, Inc. is a holding company for Pacira Pharmaceuticals, Inc. The Company's non-opioid treatments include EXPAREL (bupivacaine liposome injectable suspension), which is a long-acting, local analgesic for postsurgical pain management; ZILRETTA (triamcinolone acetonide extended-release injectable suspension), which is an extended-release, intra-articular (IA), corticosteroid injection indicated for OA knee pain, and Iovera, which is a novel handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. EXPAREL is used across multiple orthopedic procedures, including joint reconstruction, shoulder, spine, extremity procedures, and hip fractures. It is developing interventions to address debilitating conditions involving the sympathetic nervous system, such as cardiac electrical storm, chronic pain. Its clinical development programs include PCRX-201, and pMVL-Based Clinical Program.

Webull offers Pacira Biosciences Inc stock information, including NASDAQ: PCRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PCRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PCRX stock methods without spending real money on the virtual paper trading platform.